Susquehanna International Group
TFFP

Susquehanna International Group’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Susquehanna International Group’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-660
Closed -$5.78K – 13500
2023
Q3 		$5.78K Buy
+660
New +$6.18K ﹤0.01% 11773
2023
Q2 		– Sell
-570
Closed -$8.19K – 13382
2023
Q1 		$9.77K Sell
570
-396
-41% -$8.58K ﹤0.01% 12216
2022
Q4 		$25.4K Sell
966
-1,694
-64% -$80.4K ﹤0.01% 11684
2022
Q3 		$270K Buy
2,660
+670
+34% +$90.6K ﹤0.01% 10065
2022
Q2 		$281K Sell
1,990
-5,313
-73% -$741K ﹤0.01% 9745
2022
Q1 		$1.15M Sell
7,303
-7,984
-52% -$1.29M ﹤0.01% 6770
2021
Q4 		$3.39M Buy
15,287
+7,323
+92% +$1.42M ﹤0.01% 4445
2021
Q3 		$1.54M Buy
7,964
+4,138
+108% +$878K ﹤0.01% 6413
2021
Q2 		$919K Sell
3,826
-2,802
-42% -$768K ﹤0.01% 8004
2021
Q1 		$2.25M Buy
6,628
+2,330
+54% +$947K ﹤0.01% 5638
2020
Q4 		$1.54M Buy
4,298
+2,847
+196% +$1.1M ﹤0.01% 5689
2020
Q3 		$670K Buy
+1,451
New +$410K ﹤0.01% 7056

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group's TFFP Position: Q4 2023 in Review

Susquehanna International Group sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 660 shares — an estimated $5.78K sold.

Susquehanna International Group first reported a position in TFFP in Q3 2020 and held it in 12 quarters. The position peaked at $3.39M in Q4 2021. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

  • Susquehanna International Group reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 660 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $5.78K.
  • Susquehanna International Group first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • Susquehanna International Group's TFF Pharmaceuticals, Inc. Common Stock position peaked at $3.39M in Q4 2021.
  • 23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.